Vizlitics Inc.

Chappaqua, NY

UEI
N1EMHHVX3F35
CAGE
8AEB6
Primary NAICS
513210 Software Publishers
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
32 Random Farms Cir, Chappaqua, NY 10514, USA
Founded
2018
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Consumer Discretionary
  2. Consumer Services
  3. Diversified Consumer Services
  4. Specialized Consumer Services
SIC code
72 Personal Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $2,049,966

Contract awards

Grant awards

Similar vendors

About the company

Vizlitics Inc. is a for-profit corporate entity registered in SAM.gov, specializing in advanced healthcare technology solutions that leverage artificial intelligence and data analytics. The company focuses on developing innovative software platforms and decision support tools for medical research and clinical care, with a particular emphasis on oncology-related technologies. Its primary offerings include AI-driven clinical trial recruitment systems, cloud-based software-as-a-service platforms, and intelligent clinical pathway decision support tools that aim to improve patient care, streamline medical workflows, and enhance research capabilities.

Through federal contract awards, Vizlitics Inc. has secured significant contracts with civilian government agencies, particularly the National Cancer Institute. The company's most recent notable contract is a $2,049,966 firm fixed-price definitive contract for ONTRIAL, an AI-driven and EMR-integrated clinical trial recruitment tool designed to help clinical trial and provider teams recruit diverse patient populations. This contract was specifically set aside for small businesses and has an ultimate completion date of September 15, 2026. The contract demonstrates Vizlitics' capability to develop sophisticated technological solutions that address critical gaps in medical research and patient recruitment processes.

Vizlitics Inc. has also been awarded multiple federal grants from the National Cancer Institute to support innovative healthcare technology development. These grants include a project for VIPCARE, a cloud-based software platform designed to monitor, track, and optimize prostate cancer patient care protocols using advanced algorithms and Markov decision process modeling. Another significant grant supported the development of ONCOPATH, an intelligent clinical pathway decision support tool for non-small cell lung cancer treatment that aims to streamline treatment guideline analysis and pre-authorization documentation. These grant-funded projects highlight the company's commitment to creating advanced technological solutions that can improve clinical decision-making, patient follow-up, and overall healthcare efficiency in oncology.

Quick answers

Is Vizlitics Inc. registered in SAM.gov?

Yes. Vizlitics Inc.'s SAM.gov registration is active through June 6, 2027.

How much has Vizlitics Inc. received in federal contracts?

Federal contracts obligated $2,049,966 to Vizlitics Inc. in fiscal years 2023 through 2027.

What is Vizlitics Inc.'s most recent federal award?

Vizlitics Inc.'s most recent federal contract award is Ontrial: AI-driven and EMR integrated clinical trial recruitment tool used by clinical trial and provider teams for… (75N91024C00060), from National Cancer Institute (NIH), on September 16, 2024.

On GovTribe

See Vizlitics Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors